In 1998, Brain & Behavior Research Foundation Scientific Council Member and NARSAD Distinguished Investigator Grantee, Elliot S. Gershon, M.D. and colleagues made a significant discovery identifying a linkage of genes...
- Mental Illnesses
- Finding Answers
- Recovery Stories
- NARSAD Grants & Prizes
- Apply for a NARSAD Grant
- Our Scientific Council
- NARSAD Young Investigator Grant
- NARSAD Independent Investigator Grants
- NARSAD Distinguished Investigator Grant
- Klerman & Freedman Prizes
- Outstanding Achievement Prizes
- Productive Lives Awards
- Productive Lives Nomination Form
- Frequently Asked Questions (FAQs)
- Get Involved
You are hereMental Illnesses ›
Did you know that schizophrenia affects more than 1 percent of the world's population? See NARSAD Grants at work on the latest schizophrenia research
Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.
Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.
Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.
Scientific Council Member, Jeffrey A. Lieberman, M.D. of Columbia University Medical Center presents an overview of the current state of mental healthcare, offering specific recommendations on how to continue to improve...
In 1989 NARSAD Distinguished Investigator and Foundation Scientific Council member, Herbert Y. Meltzer, M.D., proved that the drug Clozapine(tm) can be used on patients with severe treatment-resistant schizophrenia....
Scientific Council Member Bita Moghaddam, PhD, led adolescent brain research at the University of Pittsburgh that identified more activity in teen brains, in the dorsal striatum, in response to ‘happy chemicals’ released...
Imagine that you are standing on a busy city street corner and you gather together the first 100 passersby who are precisely 70 years old. “In this randomly selected group, let’s assume that men and women are equally...